278 related articles for article (PubMed ID: 24703394)
1. Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
Moreno-Martet M; Espejo-Porras F; Fernández-Ruiz J; de Lago E
CNS Neurosci Ther; 2014 Sep; 20(9):809-15. PubMed ID: 24703394
[TBL] [Abstract][Full Text] [Related]
2. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O
ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1
Rodríguez-Cueto C; Santos-García I; García-Toscano L; Espejo-Porras F; Bellido M; Fernández-Ruiz J; Muñoz E; de Lago E
Biochem Pharmacol; 2018 Nov; 157():217-226. PubMed ID: 30076846
[TBL] [Abstract][Full Text] [Related]
4. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
[TBL] [Abstract][Full Text] [Related]
5. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice.
Witting A; Weydt P; Hong S; Kliot M; Moller T; Stella N
J Neurochem; 2004 Jun; 89(6):1555-7. PubMed ID: 15189359
[TBL] [Abstract][Full Text] [Related]
7. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
8. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
9. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
10. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang Q; Martin LJ
J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
[TBL] [Abstract][Full Text] [Related]
11. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.
Zhang JJ; Zhou QM; Chen S; Le WD
CNS Neurosci Ther; 2018 Dec; 24(12):1163-1174. PubMed ID: 29656576
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of CB
Fernández-Trapero M; Espejo-Porras F; Rodríguez-Cueto C; Coates JR; Pérez-Díaz C; de Lago E; Fernández-Ruiz J
Dis Model Mech; 2017 May; 10(5):551-558. PubMed ID: 28069688
[TBL] [Abstract][Full Text] [Related]
13. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
15. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of Withania somnifera extract in SOD1
Dutta K; Patel P; Julien JP
Exp Neurol; 2018 Nov; 309():193-204. PubMed ID: 30134145
[TBL] [Abstract][Full Text] [Related]
17. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Feliú A; Moreno-Martet M; Mecha M; Carrillo-Salinas FJ; de Lago E; Fernández-Ruiz J; Guaza C
Br J Pharmacol; 2015 Jul; 172(14):3579-95. PubMed ID: 25857324
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
19. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
20. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
